Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing.

Schmiegel W, Scott RJ, Dooley S, Lewis W, Meldrum CJ, Pockney P, Draganic B, Smith S, Hewitt C, Philimore H, Lucas A, Shi E, Namdarian K, Chan T, Acosta D, Ping-Chang S, Tannapfel A, Reinacher-Schick A, Uhl W, Teschendorf C, Wolters H, Stern J, Viebahn R, Friess H, Janssen KP, Nitsche U, Slotta-Huspenina J, Pohl M, Vangala D, Baraniskin A, Dockhorn-Dworniczak B, Hegewisch-Becker S, Ronga P, Edelstein DL, Jones FS, Hahn S, Fox SB.

Mol Oncol. 2017 Feb;11(2):208-219. doi: 10.1002/1878-0261.12023. Epub 2017 Jan 20.

2.

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.

van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EW, Vonk MC, Schattenberg AV, Matucci-Cerinic M, Voskuyl AE, van de Loosdrecht AA, Daikeler T, Kötter I, Schmalzing M, Martin T, Lioure B, Weiner SM, Kreuter A, Deligny C, Durand JM, Emery P, Machold KP, Sarrot-Reynauld F, Warnatz K, Adoue DF, Constans J, Tony HP, Del Papa N, Fassas A, Himsel A, Launay D, Lo Monaco A, Philippe P, Quéré I, Rich É, Westhovens R, Griffiths B, Saccardi R, van den Hoogen FH, Fibbe WE, Socié G, Gratwohl A, Tyndall A; EBMT/EULAR Scleroderma Study Group.

JAMA. 2014 Jun 25;311(24):2490-8. doi: 10.1001/jama.2014.6368.

3.

Examination of sources of diagnostic error leading to cervical cone biopsies with no evidence of dysplasia.

Carrigg A, Teschendorf C, Amaro D, Weidner N, Tipps A, Shabaik A, Peterson MR, Lin GY, Hasteh F.

Am J Clin Pathol. 2013 Apr;139(4):422-7. doi: 10.1309/AJCP6BSD0SNGQLHQ.

PMID:
23525611
4.

The clinical significance of "squamous intraepithelial lesion of indeterminate grade" as a distinct cytologic category.

Wong D, Teschendorf C, Lin GY, Hasteh F.

Am J Clin Pathol. 2012 May;137(5):753-60. doi: 10.1309/AJCPPEJT9D2RGJFH.

PMID:
22523214
5.

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients.

Dufour A, Schneider F, Hoster E, Benthaus T, Ksienzyk B, Schneider S, Kakadia PM, Sauerland MC, Berdel WE, Büchner T, Wörmann B, Braess J, Subklewe M, Hiddemann W, Bohlander SK, Spiekermann K; AML CG study group.

Ann Hematol. 2012 Jul;91(7):1051-63. doi: 10.1007/s00277-012-1423-4. Epub 2012 Feb 24.

PMID:
22362118
6.

Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p.

Neben K, Lokhorst HM, Jauch A, Bertsch U, Hielscher T, van der Holt B, Salwender H, Blau IW, Weisel K, Pfreundschuh M, Scheid C, Dührsen U, Lindemann W, Schmidt-Wolf IG, Peter N, Teschendorf C, Martin H, Haenel M, Derigs HG, Raab MS, Ho AD, van de Velde H, Hose D, Sonneveld P, Goldschmidt H.

Blood. 2012 Jan 26;119(4):940-8. doi: 10.1182/blood-2011-09-379164. Epub 2011 Dec 8.

7.

A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial.

Giessen C, von Weikersthal LF, Hinke A, Stintzing S, Kullmann F, Vehling-Kaiser U, Mayerle J, Bangerter M, Denzlinger C, Sieber M, Teschendorf C, Freiberg-Richter J, Schulz C, Modest DP, Moosmann N, Aubele P, Heinemann V.

BMC Cancer. 2011 Aug 23;11:367. doi: 10.1186/1471-2407-11-367.

8.

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.

Krug U, Röllig C, Koschmieder A, Heinecke A, Sauerland MC, Schaich M, Thiede C, Kramer M, Braess J, Spiekermann K, Haferlach T, Haferlach C, Koschmieder S, Rohde C, Serve H, Wörmann B, Hiddemann W, Ehninger G, Berdel WE, Büchner T, Müller-Tidow C; German Acute Myeloid Leukaemia Cooperative Group; Study Alliance Leukemia Investigators.

Lancet. 2010 Dec 11;376(9757):2000-8. doi: 10.1016/S0140-6736(10)62105-8. Epub 2010 Dec 3.

PMID:
21131036
9.

Efficacy of recombinant adeno-associated viral vectors serotypes 1, 2, and 5 for the transduction of pancreatic and colon carcinoma cells.

Teschendorf C, Emons B, Muzyczka N, Graeven U, Schmiegel W.

Anticancer Res. 2010 Jun;30(6):1931-5.

PMID:
20651336
10.

A rare case of chronic lymphocytic leukemia with hypercalcemia induced by elevated parathyroid hormone-related peptides.

Kampfenkel T, Baraniskin A, Teschendorf C, Schmiegel W, Massenkeil G.

Acta Haematol. 2010;124(1):57-60. doi: 10.1159/000314646. Epub 2010 Jul 9.

PMID:
20616540
11.

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG.

Lengfelder E, Haferlach C, Saussele S, Haferlach T, Schultheis B, Schnittger S, Ludwig WD, Staib P, Aul C, Grüneisen A, Kern W, Reichle A, Serve H, Berdel WE, Braess J, Spiekermann K, Wörmann B, Sauerland MC, Heinecke A, Hiddemann W, Hehlmann R, Büchner T; German AML Cooperative Group.

Leukemia. 2009 Dec;23(12):2248-58. doi: 10.1038/leu.2009.183. Epub 2009 Sep 10.

PMID:
19741727
12.

Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.

Feldmann G, Nischalke HD, Nattermann J, Banas B, Berg T, Teschendorf C, Schmiegel W, Dührsen U, Halangk J, Iwan A, Sauerbruch T, Caselmann WH, Spengler U.

Clin Cancer Res. 2006 Aug 1;12(15):4491-8.

13.

Recombinant adeno-associated and adenoviral vectors for the transduction of pancreatic and colon carcinoma.

Teschendorf C, Warrington KH Jr, Shi W, Siemann DW, Muzyczka N.

Anticancer Res. 2006 Jan-Feb;26(1A):311-7.

14.

[Colorectal carcinoma in elderly patients].

Teschendorf C, Schmiegel W.

Praxis (Bern 1994). 2005 Dec 7;94(49):1957-61. Review. German.

PMID:
16416929
15.

Combination of bortezomib, thalidomide, and dexamethasone in the treatment of relapsed, refractory IgD multiple myeloma.

Schmielau J, Teschendorf C, König M, Schmiegel W, Graeven U.

Leuk Lymphoma. 2005 Apr;46(4):567-9.

PMID:
16019485
16.

5-Fluorouracil induces arterial vasocontractions.

Südhoff T, Enderle MD, Pahlke M, Petz C, Teschendorf C, Graeven U, Schmiegel W.

Ann Oncol. 2004 Apr;15(4):661-4.

PMID:
15033676
17.

Gene therapy delivery of endostatin enhances the treatment efficacy of radiation.

Shi W, Teschendorf C, Muzyczka N, Siemann DW.

Radiother Oncol. 2003 Jan;66(1):1-9.

PMID:
12559515
18.

Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.

Teschendorf C, Warrington KH Jr, Siemann DW, Muzyczka N.

Anticancer Res. 2002 Nov-Dec;22(6A):3325-30.

PMID:
12530082
19.

Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo.

Shi W, Teschendorf C, Muzyczka N, Siemann DW.

Cancer Gene Ther. 2002 Jun;9(6):513-21.

20.

Developing VDEPT for DT-diaphorase (NQO1) using an AAV vector plasmid.

Warrington KH Jr, Teschendorf C, Cao L, Muzyczka N, Siemann DW.

Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):909-12.

PMID:
9845120

Supplemental Content

Loading ...
Support Center